STAT3 and cancer: Blocking IL-8 or inhibiting STAT3 activation disrupted these effects, indicating that the IL-8/STAT3 axis plays a crucial role in the interaction between OCSLCs and macrophages, driving tumor progression and cancer cell stemness (Figure 3) (61).